licencing

This page shows the latest licencing news and features for those working in and with pharma, biotech and healthcare.

Boehringer bolsters NASH pipeline with $870m Yuhan deal

Yuhan said that the combined molecule will be developed using technology licenced from fellow South Korean biotech Genexine, which will be eligible for a 5% of the out-licencing deal in

Latest news

AZ invests more in IO with Transgene oncolytic virus deal

Theresearch and licencing agreement centres on AZ developing five engineered oncolytic vaccinia virus candidates with Transgene, which specialises in the field.
Time running out for ‘no-deal’ Brexit medicines laws

This will be based on current UK licencing practices, but CAPs manufacturers only have until the 22 April should they decide to opt-out of this.
Chiesi's ultra-rare genetic disorder therapy wins European backing

Europe.”. Lamzede, which has been investigated in 33 patients, both adults and children, and the Italian group expects a licencing decision by the European Commission in the second quarter of 2018.
Shire licences Parion dry eye drug in $535m deal

Bolsters the Irish group's ophthalmic portfolio. Shire has agreed a licencing deal with Parion Sciences for a dry eye disease drug that bolsters its ophthalmic portfolio, a priority area for
LEO Pharma picks up AZ skin disease drugs in $1bn deal

Gains rights to eczema and psoriasis treatments

More from news
Approximately 1 fully matching, plus 8 partially matching documents found.

Latest appointments

Akari Therapeutics strengthens board

Grissinger (pictured right) has spent 22 years at Johnson &Johnson, holding positions of vice president and head of worldwide pharmaceutical licencing, as well as vice president and head of worldwide pharmaceutical

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company

mXm Medical Communications

mXm Medical Communications meets the needs of pharmaceutical marketers and medics who require a highly experienced, bespoke service from their...

Latest intelligence

Working together against COVID-19: Analysing social media conversations to see what HCPs are saying online about the global pandemic...
Vicky Bramham, Managing Director at OPEN Health PR shares tips on media relations during COVID-19: Vicky speaks with freelance health journalist Jacqui Thornton who gives her expert view on how best to approach media relations during this unprecedented time....
Are biobetters a market access opportunity?: Biobetters are biologics that have been improved compared to the marketed originator, for example in efficacy, safety, tolerability or dosing regimen....